Vivos Therapeutics 주식 가격. VVOS - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

가격

2.606

매수가

2.54

매도가

2.59

거래량

15,619

2.53 일간 변동폭 2.606

1.91 52주 범위 48.79

market_cap

8.864M

전일 종가

2.50

개장가

2.5571

최근 거래 시간

2.5626

마지막 거래 시간

22:53:05

재정 규모

US$ 39,957

VWAP

2.5582

평균 볼륨(3m)

1,399,441

발행 주식

3,401,488

배당수익률

주가수익률

-0.63

주당순이익(EPS)

-3.99

매출

13.8M

순이익

-13.58M

Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA). The Vivos treatment for mild-to-moderate OSA involves customized oral applian... Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA). The Vivos treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos oral appliances have been used to treat over 15,000 patients worldwide by more than 1,100 trained dentists. 더 보기

섹터

Surgical,med Instr,apparatus

산업

Surgical,med Instr,apparatus

웹사이트

vivos.com

본부

Wilmington, Delaware, USA

설립됨

Vivos Therapeutics Inc is listed in the Surgical,med Instr,apparatus sector of the 나스닥 with ticker VVOS. The last closing price for Vivos Therapeutics was US$2.50. Over the last year, Vivos Therapeutics shares have traded in a share price range of US$ 1.91 to US$ 48.79.

Vivos Therapeutics currently has 3,401,488 shares in issue. The market capitalisation of Vivos Therapeutics is US$8.50 million. Vivos Therapeutics has a price to earnings ratio (PE ratio) of -0.63.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

LITTLETON, Colo., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the...

Form 8-K - Current report

Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring

Vivos is poised to disrupt the very significant pediatric obstructive sleep apnea (OSA) market with new FDA clearance and new strategic marketing and distribution model Vivos’ DNA appliance now...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-0.454	-14.8366013072	3.06	3.09	2.31	335723	2.62117739	CS
4	-0.074	-2.76119402985	2.68	5.95	2.31	4018649	4.02214906	CS
12	-0.164	-5.92057761733	2.77	5.95	1.97	1399441	3.98428174	CS
26	-0.424	-13.9933993399	3.03	5.95	1.91	731092	3.83549162	CS
52	-4.144	-61.3925925926	6.75	48.79	1.91	1820147	10.58281743	CS
156	-97.144	-97.3874686717	99.75	106.75	1.91	1194999	23.93960217	CS
260	-174.144	-98.5256011315	176.75	360.25	1.91	1213407	52.81636218	CS

가장 활성
% 상승자
% 패자

기호	가격	볼륨
PEVPhoenix Motor Inc	US$ 0.76 (118.71%)	32.43M
BENFBeneficient	US$ 1.88 (57.98%)	45.36M
FORDForward Industries Inc	US$ 5.35 (52.86%)	2.82M
ADTXAditxt Inc	US$ 2.925 (50.77%)	17.03M
NCNCnoco noco Inc	US$ 0.1811 (36.58%)	97.1M
LSBLakeShore Biopharma Company Ltd	US$ 4.925 (-27.79%)	14.82k
CETXCemtrex Inc	US$ 1.92 (-25.00%)	1.16M
UPXIUpexi Inc	US$ 2.46 (-23.13%)	23.72k
ELABElevai Labs Inc	US$ 0.1027 (-22.20%)	12.31M
CHSNChanson International Holding	US$ 2.43 (-20.07%)	269.57k
NCNCnoco noco Inc	US$ 0.1818 (37.10%)	97.11M
BENFBeneficient	US$ 1.88 (57.98%)	45.36M
NVDANVIDIA Corporation	US$ 124.124 (1.04%)	36.48M
SQQQProShares UltraPro Short QQQ	US$ 7.4515 (-3.35%)	35.63M
VEVVicinity Motor Corporation	US$ 0.1702 (17.54%)	33.64M